Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: Why bother with screening at all?

Future Cardiology

Volumn 8, Issue 2, 2012, Pages 189-202

  Sharland, Gurleen ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

congenital heart disease; fetal cardiac abnormalities; fetal cardiac screening; fetal ECG

Indexed keywords

CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FETUS; FETUS DISEASE; FETUS ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; MORBIDITY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; STANDARD; SURVIVAL;

DECISION MAKING; ELECTROCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INTERNATIONALITY; NEONATAL SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL; UNITED STATES;

EID: 84858663594     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.12.15     Document Type: Review

References (88)

1. Death registrations in England and Wales, 2002: causes. Health Stat. Q. 18, 57-64 (2003
2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900 (2002 (Pubitemid 34628268)
3. Boyd PA, Tonks AM, Rankin J et al. BINOCAR Working Group. Monitoring the prenatal detection of structural fetal congenital anomalies in England and Wales: a register based study. J. Med. Screening 18, 2-7 (2011
4. Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) working group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000-2005. Circulation 123, 841-849 (2011
5. Marek J, Tomek V, Skovranek J et al. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21 year experience. Heart 97, 124-130 (2011
6. Ewer AK, Middleton LJ, Furmston AT et al.; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 378, 785-794 (2011
7. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch. Dis. Child. 71, 3-7 (1994 (Pubitemid 24238515)
8. Richmond S, Wren C. Early diagnosis of congenital heart disease. Semin. Neonatol. 6, 27-35 (2001 (Pubitemid 32127001)
9. Mellander M, Sunnegärdh J Failure to diagnose critical heart malformations in newborns before discharge - an increasing problem? Acta Paediatr. 95, 407-413 (2006 (Pubitemid 43739065)
10. Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics 103, 743-747 (1999 (Pubitemid 29274465)
11. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch. Dis. Child. 93, F33-F35 (2008
12. Sharland GK, Allan LD. Screening for congenital heart disease prenatally. Results of a 2 1/2 year study in the South East Thames Region. Br. J. Obstet. Gynaecol. 9, 220-225 (1992
13. Tegnander E, Eik-Nes S. The examiner's ultrasound experience has significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet. Gynecol. 28, 8-14 (2006 (Pubitemid 44133446)
14. Pezard P, Bonnemains L, Boussion F et al. Influence of ultrasonographers training on prenatal diagnosis of congenital heart disease: a 12 year population -based study. Prenat. Diagn. 28, 1016-1022 (2008 (Pubitemid 352789467)
15. Carvalho JS, Mavrides E, Shinebourne EA et al. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 88, 387-391 (2002
16. Hunter S, Heads A, Wyllie J et al. Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers. Heart 84, 294-298 (2000
17. McBrien A, Sands A, Craig B et al. Impact of a regional training program in fetal echocardiography for sonographers on the antenatal detection of major congenital heart disease. Ultrasound Obstet. Gynecol. 36, 279-284 (2010
18. Allan LD, Sharland GK, Milburn et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J. Am. Coll. Cardiol. 23(6), 1452-1458 (1994 (Pubitemid 24158017)
19. Allan L, Hornberger L, Sharland G. Textbook of Fetal Cardiology. Greenwich Medical Media Limited, London, UK (2000
20. Persico N, Moratella J, Lombardi CM et al. Fetal echocardiography at 11-13 weeks by transabdomainal high-frequency ultrasound. Ultrasound Obstet. Gynecol. 37, 296-301 (2011
21. Carvalho JS, Moscoso G, Ville Y. First-trimester transabdominal fetal echocardiography. Lancet 351, 1023-1027 (1998 (Pubitemid 28154379)
22. Volpe P, Ubaldo P, Volpe N et al. Fetal cardiac evaluation at 11-14 weeks by experienced obstetricians in a low-risk population. Prenat. Diagn. 31(11), 1054-1061 (2011
23. Hartege DR, Weichert J, Krappe M et al. Results of early fetal echocardiography and cumulative detection rate of congenital heart disease. Cardiol. Young 21, 505-517 (2011
24. Tworetzky W, Marshall AC. Fetal interventions for cardiac defects. Pediatr. Clin. North Am. 51, 1503-1513 (2004 (Pubitemid 39555486)
25. Arzt W, Tulzer G. Fetal surgery for cardiac lesions. Prenat. Diagn. 31, 695-698 (2011
26. Rosenberg KB, Monk C, Glickstein JS et al. Referral for fetal echocardiography is associated with increased maternal anxiety. J. Psychosom. Obstet. Gynaecol. 31, 60-69 (2010
27. Fisher J. Termination of pregnancy for fetal abnormality: the perspective of a parent support organisation. Reproduct. Health Matt. 16 (Suppl. 31), 57-65 (2008
28. Helbig A, Kaasen A, Malt UF et al. Psychological distress after recent detection of fetal malformation: short-term effect on second-trimester uteroplacental and fetoplacental circulation. BJOG 118, 1653-1657 (2011
29. Williams IA, Shaw R, Kleinman CS et al. Parental understanding of neonatal congenital heart disease. Pediatr. Cardiol. 29, 1059-1065. (2008
30. Hoehn KS, Wernovsky G, Rychik J et al. Parental decision-making in congenital heart disease. Cardiol. Young 14, 309-314 (2004
31. Axt-Fliedner R, Hartge D, Krapp M et al. Course and outcome of fetuses suspected of having coarctation of the aorta during gestation. Ultraschall. Med. 30, 269-276 (2009
32. Hornberger LK, Sahn DJ, Kleinman CS et al. Antenatal diagnosis of coarctation of the aorta: a multicenter experience. J. Am. Coll. Cardiol. 23, 417-423 (1994 (Pubitemid 24049374)
33. Head CEG, Jowett VC, Sharland GK et al. Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life. Heart 91, 1070-1074 (2005 (Pubitemid 41060018)
34. Hornberger LK, Sanders SP, Rein AJ et al. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation 92, 1531-1538 (1995
35. Gardiner HM, Belmar C, Tulzer G et al. Morphologic and functional predictors of eventual circulation in the fetus with pulmonary atresia or critical pulmonary stenosis with intact septum. J. Am. Coll. Cardiol. 51, 1299-1308 (2008 (Pubitemid 351400900)
36. Friedberg MK, Silverman NH, Moon- Grady AJ et al. Prenatal detection of congenital heart disease. J. Pediatr. 155, 26-31 (2009
37. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 354(9186), 1242-1247 (1999 (Pubitemid 29469352)
38. Allan LD, Crawford DC, Chita SK et al. Prenatal screening for congenital heart disease. Br. Med. J. 292, 1717-1719 (1986 (Pubitemid 16097907)
39. Poon LC, Huggon IC, Zidere V et al. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet. Gynecol. 29, 625-627 (2007 (Pubitemid 46975097)
40. Baker K, Sanchez-de-Toledo J, Munoz R et al. Critical congenital heart disease-utility of routine screening for chromosomal and other extracardiac malformations. Congenit. Heart Dis. doi:10.1111/j.1747-0803.00585.x. (2011) (Epub ahead of print
41. Song MS, Hu A, Dyamenahalli U et al. Extracardiac lesions and chromosomal abnormalities associated with major fetal heart defects: comparison of intrauterine, postnatal and postmortem diagnoses. Ultrasound Obstet. Gynecol. 33, 552-559 (2009
42. Raymond FL, Simpson JM, Sharland GK et al. Fetal echocardiography as a predictor of chromosomal abnormality. Lancet 350, 930 (1997 (Pubitemid 27420532)
43. Langford K, Sharland G, Simpson J. Relative risk of abnormal karyotype in fetuses found to have an atrioventricular septal defect (AVSD) on fetal echocardiography. Prenat. Diagn. 25, 137-139 (2005 (Pubitemid 40327394)
44. Copel JA, Pilu G, Kleinman CS. Extracardiac anomalies and congenital heart disease. Semin. Perinatol. 17, 89-105 (1993 (Pubitemid 23151969)
45. Burn J, Brennan P, Little J. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351, 311-316 (1998 (Pubitemid 28052695)
46. Gill HR, Splitt M, Sharland GK et al. Patterns of recurrence of congenital heart disease: an analysis of 6640 consecutive pregnancies evaluated by detailed fetal echocardiography. J. Am. Coll. Cardiol. 42, 923-929 (2003 (Pubitemid 37059755)
47. Meyer-Wittkopf M, Simpson JM, Sharland GK. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet. Gynecol. 8, 8-10 (1996 (Pubitemid 126720459)
48. Levy HL, Gulgberg P, Gutter F et al. Congenital heart disease in maternal phenylketonuria: report from the maternal PKU collaborative study. Pediatr. Res. 49, 636-642 (2001 (Pubitemid 32390851)
49. Manning N, Archer N. A study to determine the incidence of structutal congenital heart disease in monochorionic twins. Prenatal Diagnosis 26, 1062-1064 (2006 (Pubitemid 44804692)
50. Hyett J, Perdu M, Sharland G et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 318, 81-85 (1999 (Pubitemid 29188923)
51. Vogel M, Sharland GK, McElhinney DB et al. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol. Young 19, 441-445 (2009
52. McAuliffe FM, Hornberger LK, Winsor S et al. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. Am. J. Obstet. Gynecol. 191, 1486-1490 (2004 (Pubitemid 39421619)
53. Clur SA, Ottencamp J, Cilardo CM. The nuchal translucency and the fetal heart: a literature review. Prenatal Diagnosis 29, 739-748 (2009
54. Rychik J, Ayres N, Cuneo B et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J. Am. Soc. Echocardiogr. 17, 803-810 (2004 (Pubitemid 38858033)
55. Allan L, Dangel J, Fesslova V et al; Fetal Cardiology Working Group; Association for European Paediatric Cardiology. Recommendations for the practice of fetal cardiology in Europe. Cardiol. Young 14, 109-114 (2004
56. Lee W, Allan L, Carvalho JS et al; ISUOG Fetal Echocardiography Task Force. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet. Gynecol. 32, 239-242 (2008
57. Fetal Echocardiography Task Force; American Institute of Ultrasound in Medicine Clinical Standards Committee; American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. AIUM practice guideline for the performance of fetal echocardiography. J. Ultrasound Med. 30, 127-136 (2011
58. Wigton TR, Sabbagha RE, Tamura RK et al. Sonographic diagnosis of congenital heart disease: comparison between the four-chamber view and multiple cardiac views. Obstet. Gynecol. 82, 219-224 (1993 (Pubitemid 23217662)
59. Kirk JS, Riggs TW, Comstock CH et al. Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four chamber view. Obstet. Gynecol. 84, 427-431 (1994 (Pubitemid 24267305)
60. Achiron R, Glaser J, Gelernter I et al. Extended fetal echocardiographic examination for detecting cardiac malformations in low-risk pregnancies. BMJ 304, 671-374 (1992
61. Khoo NS, Van Essen P, Richardson M et al. Effectiveness of prenatal diagnosis of congenital heart defects in south Australia: a population analysis 1999-2003. Aust. NZ J. Obstet. Gynaecol. 48, 559-563 (2008
62. Acherman RJ, EVans WN, Luna CF et al. Prenatal detection of congenital heart disease in southern Nevada: the need for universal fetal cardiac evaluation. J. Ultrasound Med. 26, 1715-1719 (2007 (Pubitemid 350210079)
63. Bricker L, Garcia J, Henderson J et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views Health Technol. Assess. 4(16) i-vi, 1-193 (2000
64. Ewigman BG, Crane JP, Frigoletto FD et al. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N. Engl. J. Med. 329, 821-827 (1993 (Pubitemid 23267208)
65. Germanakis I, Sifakis S. The impact of fetal echocardiography on the prevalence of liveborn congenital heart disease. Pediatr. Cardiol. 27, 465-472 (2006 (Pubitemid 44222400)
66. Chew C, Stone S, Donath SM et al. Impact of antenatal screening on the presentation of infants with congenital heart disease to a cardiology unit. J. Paediatr. Child Health 42, 704-708 (2006 (Pubitemid 44581624)
67. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79, 576-581 (1998 (Pubitemid 28289280)
68. Johnson BA, Ades A. Delivery room and early postnatal management of neonates who have prenatally diagnosed congenital heart disease. Clin. Perinatol. 32, 921-946 (2005 (Pubitemid 41736010)
69. Verheijen PM, Lisowski LA, Stoutenbeek P et al. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J. Thorac. Cardiovasc. Surg. 121, 798-803 (2001
70. Kumar RK, Newburger JW, Gauvreau K et al. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am. J. Cardiol. 83, 1649-1653 (1999 (Pubitemid 29288009)
71. Tworetzky W, McElhinney DB, Reddy VM et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 103, 1269-1273 (2001 (Pubitemid 32221351)
72. Mahle WT, Clancy RR, McGaurn SP et al. Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics 107, 1277-1282 (2001 (Pubitemid 32525202)
73. Franklin O, Burch M, Manning N et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 87, 67-69 (2002 (Pubitemid 34074958)
74. Blyth M, Howe D, Gnanapragasam J et al. The hidden mortality of transposition of the great arteries and survival adVantage provided by prenatal diagnosis. BJOG 115, 1096-1100 (2008 (Pubitemid 352000368)
75. Jaeggi ET, Sholler GF, Jones OD et al. Comparative analysis of pattern, management and outcome of pre- versus post-natally diagnosed major congenital heart disease: a population-based study. Ultrasound. Obstet. Gynecol. 17, 380-385 (2001 (Pubitemid 32499867)
76. Bonnet D, Coltri A, Butera G et al. Fetal detection of transposition of the great arteries reduces morbidity and mortality in newborn infants. Circulation 99, 916-918 (1999 (Pubitemid 29094306)
77. Khoshnood B, De Vigan C, Vodovar V et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 115, 95-101 (2005 (Pubitemid 43046286)
78. Sivarajan V, Penny DJ, Filan P et al. Impact of antenatal diagnosis of hypoplastic left heart syndrome on the clinical presentation and surgical outcomes: the Australian experience. J. Paediatr. Child Health 45, 112-117 (2009
79. Brown KL, Ridout DA, Hoskote A et al. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart 92, 1298-1302 (2006 (Pubitemid 44298886)
80. Kipps AK, Feuille C, Azakie A et al. Prenatal diagnosis of hypoplastic left heart syndrome in current era. Am. J. Cardiol. 108, 421-427 (2011
81. Levey A, Glickstein JS, Kleinman CS et al. The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes. Pediatr. Cardiol. 5, 587-597 (2010
82. Punn R, Silverman NH. Fetal predictors of urgent balloon atrial septostomy in neonates with complete transposition. J. Am. Soc. Echocardiogr. 24, 425-430 (2011
83. Arzt W, Wertaschnigg D, Veit I et al Intrauterine aortic valvuloplasty in fetuses with critical aortic stenosis: experience and results of 24 procedures. Ultrasound Obstet. Gynecol. 37, 689-695 (2011
84. McElhinney DB, Marshall AC, Wilkins-Haug LE et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 13, 1482-1490 (2009
85. Gardiner HM. The case for fetal cardiac intervention Heart 95, 1648-1652 (2009
86. Jegatheeswaran A, Oliveira C, Batsos C et al. Costs of prenatal detection of congenital heart disease. Am J Cardiol. 108(12), 1808-1814 (2011
87. Griebsch I, Knowles RL, Brown J et al. Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis. Int. J. Technol. Assess. Health Care 23(2), 192-204 (2007 (Pubitemid 46642727)
88. de-Wahl Granelli A, Wennergren M, Sandberg K et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 338, 145-149 (2009)